Becker, G., Lespine, L.-F., Bahri, M. A., Serrano Navacerrada, M. E., Lemaire, C., Luxen, A., Tirelli, E., & Plenevaux, A. (2022). Exercise against cocaine sensitization in mice: a [18F]fallypride micro-PET study. Brain Communications, 4 (1), 294. doi:10.1093/braincomms/fcab294 |
Salmon, E., Bahri, M. A., Plenevaux, A., Becker, G., Seret, A., Delhaye, E., Degueldre, C., Balteau, E., Lemaire, C., Luxen, A., & Bastin, C. (09 August 2021). In vivo exploration of synaptic projections in frontotemporal dementia. Scientific Reports, 11, 16092. doi:10.1038/s41598-021-95499-1 |
Bastin, C., Bahri, M. A., Giacomelli, F., Miévis, F., Lemaire, C., Degueldre, C., Balteau, E., Guillaume, B., & Salmon, E. (2021). Familiarity in Mild Cognitive Impairment as a function of patients’ clinical outcome four years later. Alzheimer Disease and Associated Disorders, 35 (4), 321-326. doi:10.1097/WAD.0000000000000466 |
Bastin, C., Giacomelli, F., Miévis, F., Lemaire, C., Guillaume, B., & Salmon, E. (2021). Anosognosia in Mild Cognitive Impairment: Lack of awareness of memory difficulties characterizes prodromal Alzheimer’s disease. Frontiers in Psychiatry, 12, 631518. doi:10.3389/fpsyt.2021.631518 |
Becker, G., Michel, A., Bahri, M. A., Mairet-Coello, G., Lemaire, C., Deprez, T., Freyssin, A., Jacquin, L., Hustadt, F., De Wolf, C., Caruso, M., Frequin, J.-M., Gillent, E., Bezard, E., Garraux, G., Luxen, A., Citron, M., Downey, P., & Plenevaux, A. (2021). Monitoring of a progressive functional dopaminergic deficit in the A53T-AAV synuclein rats by combining 6-[ 18 F]fluoro-L-m-tyrosine imaging and motor performances analysis. Neurobiology of Aging, 107, 142-152. doi:10.1016/j.neurobiolaging.2021.07.012 |
Goutal, S., Guillermier, M., Becker, G., Gaudin, M., Bramoulle,, Y., Luxen, A., Lemaire, C., Plenevaux, A., SALMON, E., Hantraye, P., Barret, O., & Van Camp, N. (2021). The pharmacokinetics of [(18)F]UCB-H revisited in the healthy non-human primate brain. EJNMMI Res, 11 (1), 36. doi:10.1186/s13550-021-00777-8 |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpre, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (2020). Exploring with [(18)F]UCB-H the in vivo Variations in SV2A Expression through the Kainic Acid Rat Model of Temporal Lobe Epilepsy. Molecular Imaging and Biology. doi:10.1007/s11307-020-01488-7 |
Trump, L., Lemos, A., Jacq, J., Pasau, P., Lallemand, B., Mercier, J., Génicot, C., Luxen, A., & Lemaire, C. (2020). Development of a General Automated Flow Photoredox 18F-Difluoromethylation of N-Heteroaromatics in an AllinOne Synthesizer. Organic Process Research and Development. doi:10.1021/acs.oprd.9b00442 |
Nagachinta, S., Becker, G., Dammicco, S., Serrano Navacerrada, M. E., LEROI, N., Bahri, M. A., Plenevaux, A., Lemaire, C., Lopez, R., Luxen, A., & de la Fuente, M. (2020). Radiolabelling of lipid-based nanocarriers with fluorine-18 for in vivo tracking by PET. Colloids and Surfaces B: Biointerfaces, 188, 110793. doi:10.1016/j.colsurfb.2020.110793 |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Seret, A., Mestdagh, N., Mercier, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 May 2019). Evaluating the In Vivo Specificity of [18F]UCB-H for the SV2A Protein, Compared with SV2B and SV2C in Rats Using microPET. Molecules, 24 (9), 1705. doi:10.3390/molecules24091705 |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Germonpré, C., Lemaire, C., Giacomelli, F., Mievis, F., Luxen, A., Salmon, E., Rogister, B., Raedt, R., & Plenevaux, A. (19 March 2019). Longitudinal in vivo evaluation of brain synaptic density with [18F]UCB-H through the different phases in the kainic acid rat model of temporal lobe epilepsy [Paper presentation]. 14th European Molecular Imaging Meeting, Glasgow, United Kingdom. |
Manos-Turvey, A., Becker, G., Francotte, P., Serrano Navacerrada, M. E., Luxen, A., Pirotte, B., Plenevaux, A., & Lemaire, C. (11 February 2019). Fully Automated Synthesis and Evaluation of [ 18 F]BPAM121: Potential of an AMPA Receptor Positive Allosteric Modulator as PET Radiotracer. ChemMedChem, 14 (7), 788-795. doi:10.1002/cmdc.201800816 |
Lemos, A., Lemaire, C., & Luxen, A. (2019). Progress in Difluoroalkylation of Organic Substrates by Visible Light Photoredox Catalysis. Advanced Synthesis and Catalysis, 361, 1500-1537. doi:10.1002/adsc.201801121 |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Seret, A., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2019). Quantification of [18F]UCB-H Binding in the Rat Brain: From Kinetic Modelling to Standardised Uptake Value. Molecular Imaging and Biology, 21, 888-897. doi:10.1007/s11307-018-1301-0 |
Trump, L., Lemos, A., Lallemand, B., Pasau, P., Mercier, J., Lemaire, C., Luxen, A., & Genicot, C. (2019). Late-Stage (18) F-Difluoromethyl Labeling of N-Heteroaromatics with High Molar Activity for PET Imaging. Angewandte Chemie (International ed. in English), 58 (37), 13149-13154. doi:10.1002/anie.201907488 |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Raedt, R., & Plenevaux, A. (18 October 2018). THE SV2A PROTEIN: IMAGING SYNAPTIC DENSITY DURING THE PROGRESSION OF THE TEMPORAL LOBE EPILEPSY IN THE KASE RAT MODEL [Poster presentation]. MINC 2018 – Multimodal Neuroimaging Cologne, Köln, Germany. |
Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20th EURON PhD days, Brussels, Belgium. |
Serrano Navacerrada, M. E., Raedt, R., Becker, G., Bahri, M. A., Mievis, F., Lemaire, C., Giacomelli, F., Salmon, E., Luxen, A., & Plenevaux, A. (13 September 2018). EPILEPSY AND THE SV2A PROTEIN: new insights about the disease [Paper presentation]. 20TH EURON PhD DAYS, Leuven, Belgium. |
Serrano Navacerrada, M. E., Bahri, M. A., Becker, G., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., & Plenevaux, A. (22 March 2018). [18F]UCB-H BINDING QUANTIFICATION IN RAT BRAIN: FROM MODELLING TO SUV [Poster presentation]. 13th European Molecular Imaging Meeting - EMIM 2018, San Sebastián, Spain. |
Salvé, M., Avohou, T. H., Monbaliu, J.-C., Lebrun, P., Lemaire, C., Damblon, C., De Tullio, P., Hubert, P., Hustinx, R., & Luxen, A. (12 February 2018). NOTA‐PRGD2 and NODAGA‐PRGD2: Bioconjugation, characterization, radiolabelling, and design space. Journal of Labelled Compounds and Radiopharmaceuticals, 61, 487-500. doi:10.1002/jlcr.3613 |
Denoël, T., Lemaire, C., & Luxen, A. (2018). Progress in lanthionine and protected lanthionine synthesis. Chemistry. doi:10.1002/chem.201801115 |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (December 2017). Sv2a protein levels in the kainic acid epilepsy rat model during the acute phase. Epilepsia, 58 (Supplement S5), 1–S225. |
Dammicco, S., Goux, M., Lemaire, C., Becker, G., Bahri, M. A., Plenevaux, A., Cinier, M., & Luxen, A. (2017). Regiospecific radiolabelling of Nanofitin on Ni Magnetic Beads with [18F]FBEM and in vivo PET studies. Nuclear Medicine and Biology. doi:10.1016/j.nucmedbio.2017.04.006 |
Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Pirotte, B., & Francotte, P. (August 2017). Design and Synthesis of [18F]BPAM121, a PET-Probe Targeting AMPA-subtype Glutamatergic Receptors [Poster presentation]. EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry, Vienne, Austria. |
Manos-Turvey, A., Lemaire, C., Becker, G., Plenevaux, A., Luxen, A., Francotte, P., & Pirotte, B. (July 2017). Synthesis of [18F]BPAM121: An AMPAR Modulator with Potential as a PET Probe [Poster presentation]. RICT 2017, Drug Discovery and Selection, 53rd International Conference on Medicinal Chemistry, Toulouse, France. |
Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (26 June 2017). Pharmacokinetic characterization of [18F]UCB-H PET radiopharmaceutical in the rat brain. Molecular Pharmaceutics, 14 (8), 2719-2725. doi:10.1021/acs.molpharmaceut.7b00235 |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (10 June 2017). Evaluation of dopaminergic terminal loss in a Parkinson's disease rat model, [18F]FDOPA versus [18F]FMT microPET [Paper presentation]. SNMMI 2017 Annual Meeting, Denver, United States. |
Manos-Turvey, A., Lemaire, C., Deverdenne, F., Luxen, A., Francotte, P., & Pirotte, B. (June 2017). [18F]BPAM121: An AMPAR Modulator with Potential as a PET Probe [Poster presentation]. Royal Society of Chemistry Medicinal Chemistry Residential School, Loughborough, United Kingdom. |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (May 2017). Comparative assessment of 6-[18F]fluoro-L-m-tyrosine and 6-[18F]fluoro-L-dopa to evaluate dopaminergic presynaptic integrity in a Parkinson’s disease rat model. Journal of Neurochemistry, 141, 626-635. doi:10.1111/jnc.14016 |
Becker, G., Lespine, L.-F., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (05 April 2017). Functional correlates of the protective effects of free wheel-running against cocaine psychomotor sensitization on dopamine D2 receptors: a [18F]Fallypride microPET study [Paper presentation]. European Molecular Imaging Meeting - EMIM 2017, Cologne, Germany. |
Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (19 February 2017). Noninvasive quantification of [18F]UCB-H binding using microPET and population-based input function [Poster presentation]. Neuroimaging - from Molecules to Networks - TOPIM 2017, Les Houches, France. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (01 February 2017). Evaluating the specificity of [18F] UCB-H for the isoform SV2A, compared with isoforms SV2B and SV2C [Poster presentation]. GIGA Day 2017, Liège, Belgium. |
Becker, G., Lespine, L.-F., Serrano Navacerrada, M. E., Bahri, M. A., Luxen, A., Lemaire, C., Tirelli, E., & Plenevaux, A. (2017). Neuro-functional correlates of the protective effects of exercise against cocaine sensitization and dopamine D2 receptors density: a [18F]Fallypride microPET study [Paper presentation]. World Molecular Imaging Congress - WMIC 2017, Philadelphia, United States. |
Maneuski, D., Giacomelli, F., Lemaire, C., Pimlott, S., Plenevaux, A., Owens, J., O'Shea, V., & Luxen, A. (2017). On the use of positron counting for radio-Assay in nuclear pharmaceutical production. Applied Radiation and Isotopes, 125, 9-14. doi:10.1016/j.apradiso.2017.03.021 |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN THE KAINIC ACID EPILEPSY RAT MODEL [Poster presentation]. 12th European Molecular Imaging Meeting (EMIM 2017), Cologne, Germany. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). IN VIVO STUDY OF THE SV2A PROTEIN IN AN EPILEPTIC RAT MODEL [Poster presentation]. 3rd Belgium Molecular Imaging Congress (BMIC 2017), Brussels, Belgium. |
Serrano Navacerrada, M. E., Becker, G., Bahri, M. A., Warnier, C., Aerts, J., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., & Plenevaux, A. (2017). [18F]UCB-H RADIOTRACER AS A TOOL TO UNDERSTAND THE ROLE OF THE SV2A PROTEIN [Poster presentation]. PhD Student Day, Liège, Belgium. |
Serrano Navacerrada, M. E., Aerts, J., Bahri, M. A., Becker, G., Giacomelli, F., Lemaire, C., Luxen, A., Mercier, J., Mestdagh, N., Mievis, F., Plenevaux, A., Salmon, E., & Warnier, C. (18 November 2016). EVALUATING THE SPECIFICITY OF [18F]UCB-H FOR THE ISOFORM SV2A, COMPARED WITH ISOFORMS SV2B AND SV2C [Poster presentation]. MedChem 2016 PET & Imaging : From Chemistry Lab to Clinical Applications, Mont-Saint-Guibert, Belgium. |
Warnier, C., Lemaire, C., Becker, G., Zaragoza, G., Giacomelli, F., Aerts, J., Otabashi, M., Bahri, M. A., Mercier, J., Plenevaux, A., & Luxen, A. (06 September 2016). Enabling efficient PET imaging of Synaptic Vesicle glycoprotein 2A (SV2A) with a robust and one-step radiosynthesis of a highly potent 18F-labelled ligand ([18F]UCB-H). Journal of Medicinal Chemistry, 59, 8955-8966. doi:10.1021/acs.jmedchem.6b00905 |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (July 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat model: comparison between [18F]FMT and [18F]FDOPA [Paper presentation]. World Molecular Imaging Congress 2015, Honolulu, United States. |
Henrottin, J., Lemaire, C., Egrise, D., Zervosen, A., Van den Eynde, B., Plenevaux, A., Franci, X., Goldman, S., & Luxen, A. (June 2016). Fully automated radiosynthesis of N1-[18F]fluoroethyl-tryptophan and study of its biological activity as a new potential substrate for indoleamine 2,3-dioxygenase PET imaging. Nuclear Medicine and Biology, 43 (6), 379-389. doi:10.1016/j.nucmedbio.2016.03.001 |
Simon, J., Lamborelle, N., Zervosen, A., Lemaire, C., Joris, B., & Luxen, A. (2016). Development of solid-supported methodology for the preparation of peptidoglycan fragments containing (2S,6R)-diaminopimelic acid. Tetrahedron Letters. doi:10.1016/j.tetlet.2016.02.098 |
Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (09 March 2016). EVALUATION OF SV2Alox/Cre TRANSGENIC MICE USING [18F]UCB-H IN VITRO AUTORADIOGRAPHY [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Luxen, A., Garraux, G., Lemaire, C., & Plenevaux, A. (08 March 2016). In vivo quantification of dopaminergic terminals loss in Parkinson’s Disease rat with AAV-induced overexpression of alpha-synuclein: a [18F]FMT microPET study [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
Becker, G., Warnier, C., Serrano Navacerrada, M. E., Bahri, M. A., Mercier, J., Luxen, A., Lemaire, C., Salmon, E., & Plenevaux, A. (08 March 2016). In vivo evaluation of [18F]UCB-H binding at SV2A protein, through a new and efficient radiosynthesis of [18F]UCB-H [Poster presentation]. European Molecular Imaging Meeting - EMIM 2016, Utrecht, Netherlands. |
Serrano Navacerrada, M. E., Becker, G., MENTEN, C., Bahri, M. A., Warnier, C., Mievis, F., Giacomelli, F., Lemaire, C., Salmon, E., Luxen, A., Rogister, B., & Plenevaux, A. (04 September 2015). EVALUATION OF SV2Alox/Cre TRANSGENIC MOUSE USING [18F]UCB-H IN IN VITRO AUTORADIOGRAPHY [Poster presentation]. International Symposium "Aging and sleep: Perks for longevity?, Liège, Belgium. |
Lemaire, C., Libert, L., Franci, X., Genon, J.-L., Kuci, S., Giacomelli, F., & Luxen, A. (26 May 2015). Automated production at the curie level of no-carrier-added 6-[18F]fluoro-L-dopa and 2-[18F]fluoro-L-tyrosine on a FASTlab synthesizer. Journal of Labelled Compounds, 58, 281-290. doi:10.1002/jlcr.3291 |
Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (09 May 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial. Tijdschrift voor Nucleaire Geneeskunde, 37 (3), 1457-1458. |
Seret, A., Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Luxen, A., Lemaire, C., & Plenevaux, A. (09 May 2015). [18F]FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. 17th Symposium of the Belgian Society of Nuclear Medicine, Maastricht, Netherlands. |
Dammicco, S., Lemaire, C. (Other coll.), Cinier, M. (Other coll.), Plenevaux, A. (Other coll.), & Luxen, A. (Other coll.). (May 2015). Regiospecific radiolabeling of Nanofitin on Ni Magnetic Beads with 18F-FBEM and in vivo PET studies [Poster presentation]. International Symposium on Radiophamaceutical Siences. |
Henrottin, J., Lemaire, C., Zervosen, A., Egrise, D., Plenevaux, A., Doumont, G., Goldman, S., & Luxen, A. (May 2015). Fully automated radiosynthesis of 1-[18F]FETrp, a potential substrate for indoleamine 2,3-dioxygenase PET imaging [Poster presentation]. The 21st International Symposium on Radiopharmaceutical Sciences (ISRS 2015), University of Missouri, Columbia, Missouri, United States. |
Otabashi, M., Cascione, C., Lemaire, C., Morelle, J.-L., & Philippart, G. (May 2015). High output [18F]FDOPA on AllInOne (Trasis) at commercial scale. Journal of Labelled Compounds and Radiopharmaceuticals, 58, 369. |
Henrottin, J., Lemaire, C., Zervosen, A., Egrise, D., Doumont, G., Plenevaux, A., Goldman, S., & Luxen, A. (02 April 2015). N1-(2-[18F]Fluoroethyl)-tryptophan: fully automated radiosynthesis, and study as potential substrate for indoleamine 2,3-dioxygenase PET imaging [Paper presentation]. La Journée-Rencontre des Jeunes Chimistes de la Société Royale de Chimie - 8ème édition, Namur, Belgium. |
Becker, G., Bahri, M. A., Michel, A., Hustadt, F., Garraux, G., Lemaire, C., & Plenevaux, A. (18 March 2015). 18F-FMT: a reliable PET tracer for in vivo evaluation of dopaminergic dysfunction in Parkinson’s Disease rat model [Poster presentation]. European Molecular Imaging Meeting EMIM 2015, Tübingen, Germany. |
Bahri, M. A., Stifkens, M., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., ... SALMON, E. (27 January 2015). [18F]UCB-H as a new PET radiotracer for Synaptic vesicle protein 2A: A first clinical trial [Poster presentation]. 2015 GIGA day, Liège, Belgium. |
Henrottin, J., Zervosen, A., Lemaire, C., Sapunaric, F., Laurent, S., Van den Eynde, B., Goldman, S., Plenevaux, A., & Luxen, A. (January 2015). N1-Fluoroalkyltryptophan analogues: synthesis and in vitro study as potential substrates for indoleamine 2,3-dioxygenase. ACS Medicinal Chemistry Letters, 6, 260-265. doi:10.1021/ml500385d |
Warnock, G., Aerts, J., Bahri, M. A., Bretin, F., Lemaire, C., Giacomelli, F., Mievis, F., Mestdagh, N., Buchanan, T., Valade, A., Mercier, J., Wood, M., Gillard, M., Seret, A., Luxen, A., SALMON, E., & Plenevaux, A. (01 August 2014). Evaluation of [18F]UCB-H as a novel PET tracer for synaptic vesicle protein 2A in the brain. Journal of Nuclear Medicine, 55 (8), 1336-1341. doi:10.2967/jnumed.113.136143 |
Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Giacomelli, F., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (06 June 2014). [18F]UCB-H AS A NEW PET RADIOTRACER FOR SYNAPTIC VESICLE PROTEIN 2A [Poster presentation]. European Molecular Imaging Meeting - EMIM 2014, Antwerp, Belgium. |
Henrottin, J., Zervosen, A., Lemaire, C., Sapunaric, F., Laurent, S., Galleni, M., Van den Eynde, B., Goldman, S., Plenevaux, A., & Luxen, A. (June 2014). Synthesis of N-fluoroalkyl-tryptophan and study of their biological activity as potential substrates for indoleamine 2,3-dioxygenase [Poster presentation]. French-American Chemical society Symposium - FACS XV. |
Lamborelle, N., Simon, J., Lemaire, C., Joris, B., & Luxen, A. (June 2014). Stereoselective synthesis of stable isotopomers of meso -2,6-diaminopimelic acid [Poster presentation]. 15th Tetrahedron Symposium Challenges in Bioorganic and Organic Medicinal Chemistry, Londres, United Kingdom. |
Bahri, M. A., Bastin, C., Aerts, J., Bretin, F., Warnock, G., Buchanan, T., Mella, C., Mestdagh, N., Otoul, C., Koester, F., Valade, A., Mercier, J., Lemaire, C., Mievis, F., Léonard, M., Seret, A., Luxen, A., Plenevaux, A., & Salmon, E. (27 May 2014). [18F]UCB-H AS A BRAIN SV2A RADIOTRACER: A FIRST CLINICAL TRIAL [Poster presentation]. XIII Turku PET Symposium, Turku, Finland. |
Bretin, F., Mauxion, T., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Luxen, A., Bardies, M., Seret, A., & Plenevaux, A. (May 2014). Hybrid MicroPET Imaging for Dosimetric Applications in Mice: Improvement of Activity Quantification in Dynamic MicroPET Imaging for Accelerated Dosimetry Applied to 6-[ 18 F] Fluoro- L -DOPA and 2-[ 18 F]Fluoro- L -Tyrosine. Molecular Imaging and Biology, 16 (3), 383-394. doi:10.1007/s11307-013-0706-z |
Bastin, C., Bahri, M. A., Mievis, F., Lemaire, C., Collette, F., Genon, S., Simon, J., Guillaume, B., Diana, R. A., Yonelinas, A. P., & Salmon, E. (2014). Associative memory and its cerebral correlates in Alzheimer’s disease: Evidence for distinct deficits of relational and conjunctive memory. Neuropsychologia, 63, 99-106. doi:10.1016/j.neuropsychologia.2014.08.023 |
Denoel, T., Zervosen, A., Gerards, T., Lemaire, C., Joris, B., Blanot, D., & Luxen, A. (2014). Stereoselective synthesis of lanthionine derivatives in aqueous solution and their incorporation into the peptidoglycan of Escherichia coli. Bioorganic and Medicinal Chemistry, 22 (17), 4621-8. doi:10.1016/j.bmc.2014.07.023 |
Denoel, T., Zervosen, A., Lemaire, C., Joris, B., Herve, M., Blanot, D., Zaragoza, G., & Luxen, A. (2014). Enantioselective synthesis of [small alpha]-benzylated lanthionines and related tripeptides for biological incorporation into E. coli peptidoglycan. Organic and Biomolecular Chemistry. doi:10.1039/c4ob01476f |
Denoël, T., Zervosen, A., Lemaire, C., Plenevaux, A., & Luxen, A. (2014). Synthesis of protected α-alkyl lanthionine derivatives. Tetrahedron, 70 (30), 4526 - 4533. doi:10.1016/j.tet.2014.05.004 |
Léonard, M., Aerts, J., Voccia, S., Lemaire, C., Morelle, J.-L., Phillipart, G., & Luxen, A. (22 October 2013). Fully Automated Production of 68Ga-DOTA-NOC with a Trasis miniAIO® Synthesizer [Poster presentation]. EANM'13 - Annual Congress of the European Association of Nuclear Medicine, Lyon, France. |
Flagothier, J., Warnier, C., Dammicco, S., Lemaire, C., & Luxen, A. (10 October 2013). Synthesis of [18F]4-(4-fluorophenyl)-1,2,4-triazole-3,5-dione: an agent for specific radiolabelling of tyrosine. RSC Advances, 3, 24936. doi:10.1039/c3ra44666b |
Warnock, G., Turtoi, A., Blomme, A., Bretin, F., Bahri, M. A., Lemaire, C., Libert, L., Seret, A., Luxen, A., Castronovo, V., & Plenevaux, A. (22 August 2013). In vivo PET/CT in a human glioblastoma chicken chorioallantoic membrane model: A new tool for oncology and radiotracer development. Journal of Nuclear Medicine, 54 (10), 1782-1788. doi:10.2967/jnumed.112.117150 |
Libert, L., Franci, X., Plenevaux, A., OOi, T., Maruoka, K., Luxen, A., & Lemaire, C. (July 2013). Production at the Curie Level of No-Carrier-Added 6-18F-Fluoro-L-Dopa. Journal of Nuclear Medicine, 54 (7), 1154-1161. doi:10.2967/jnumed.112.112284 |
Warnier, C., Lemaire, C., Goblet, D., Aerts, J., Flagothier, J., Libert, L., & Luxen, A. (16 May 2013). Preliminary evaluation of two recently developed evaporation-free [18F]fluorination methods on aromatic precursors [Poster presentation]. 20th symposium on radiopharmaceutical sciences, Jeju, South Korea. |
Flagothier, J., Warnier, C., Lemaire, C., & Luxen, A. (2013). Synthesis of [18F]4-(4-fluorophenyl)-1,2,4-triazole-3,5-dione: an agent for specific radiolabelling of tyrosine. In J. Flagothier (Ed.), Journal of Labelled Compounds and Radiopharmaceuticals. Wiley. |
Bretin, F., Warnock, G., Bahri, M. A., Aerts, J., Mestdagh, N., Buchanan, T., Valade, A., Mievis, F., Giacomelli, F., Lemaire, C., Luxen, A., Salmon, E., Seret, A., & Plenevaux, A. (07 May 2013). Preclinical radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H. EJNMMI Research, 3 (1), 35. doi:10.1186/2191-219X-3-35 |
Henrottin, J., Zervosen, A., Lemaire, C., Galleni, M., & Luxen, A. (May 2013). Automated radiosynthesis of 1-(2-[18F]fluoroethyl)-tryptophan, a potential substrate for indoleamine 2,3-dioxygenase PET imaging [Poster presentation]. The 20th International Symposium on Radiopharmaceutical Sciences - ISRS 2013, Jéju, South Korea. |
Libert, L., Lemaire, C., Giacomelli, F., Léonard, M., Plenevaux, A., Franci, X., & Luxen, A. (May 2013). Quality controls of no-carrier-added aromatic amino acids such as FDOPA and FTYR produced at curie level [Poster presentation]. The 20th International Symposium on Radiopharmaceutical Science, Jeju, South Korea. |
Aerts, J., Otabashi, M., Giacomelli, F., Warnock, G., Bahri, M. A., Bretin, F., Sauvage, X., Thielen, C., Lemaire, C., Salmon, E., Plenevaux, A., & Luxen, A. (2013). Radiosynthesis and first small animal microPET imaging of [18F]UCB-H, a new fluorine-18 labelled tracer targeting synaptic vesicle protein 2A (SV2A) [Paper presentation]. 26th Annual Congress of the EANM. |
Bastin, C., Feyers, D., Jedidi, H., Bahri, M. A., Degueldre, C., Lemaire, C., Collette, F., & Salmon, E. (2013). Episodic autobiographical memory in amnestic Mild Cognitive Impairment: What are the neural correlates? Human Brain Mapping, 34, 1811-1825. doi:10.1002/hbm.22032 |
Garraux, G.* , Phillips, C.* , Schrouff, J., Kreisler, A., Lemaire, C., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destée, A., & Salmon, E. (2013). Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes. NeuroImage: Clinical, 2, 883-893. doi:10.1016/j.nicl.2013.06.004 * These authors have contributed equally to this work. |
Bretin, F., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Phillips, C., Plenevaux, A., Luxen, A., & Seret, A. (October 2012). Dosimetry for 6-[18F]Fluoro-L-DOPA in Humans Based on Biodistribution in Mice [Poster presentation]. EANM'12 Annual Congress of the European Association of Nuclear Medicine, Milano, Italy. |
Warnock, G., Turtoi, A., Blomme, A., Gonzalez, A., Bretin, F., Bahri, M. A., Lemaire, C., Seret, A., Castronovo, V., Luxen, A., & Plenevaux, A. (October 2012). In Ovo PET Imaging Of A Human Colorectal Carcinoma Model In Chicken Chorioallantoic Membrane [Poster presentation]. Annual Congress of the European Association of Nuclear Imaging, Milan, Italy. |
Bretin, F., Warnock, G., Bahri, M. A., Libert, L., Lemaire, C., Phillips, C., Seret, A., Luxen, A., & Plenevaux, A. (September 2012). Dosimetry for 6-[18F]Fluoro-L-DOPA in humans based on in vivo microPET scans and ex vivo tissue distribution in mice [Poster presentation]. World Molecular Imaging Congress, Dublin, Ireland. |
Lemaire, C., Libert, L., Plenevaux, A., Aerts, J., Franci, X., & Luxen, A. (24 March 2012). Fast and reliable method for the preparation of ortho- and para-[18F]fluorobenzyl halide derivatives: Key intermediates for the preparation of no-carrier-added PET aromatic radiopharmaceuticals. Journal of Fluorine Chemistry, 138, 48-55. doi:10.1016/j.jfluchem.2012.03.015 |
Bastin, C., Feyers, D., Souchay, C., Guillaume, B., Pepin, J.-L., Lemaire, C., Degueldre, C., Collette, F., & Salmon, E. (2012). Frontal and posterior cingulate metabolic impairment in the behavioural variant of frontotemporal dementia with impaired autonoetic consciousness. Human Brain Mapping, 33, 1268-1278. doi:10.1002/hbm.21282 |
Warnock, G., Bahri, M. A., Goblet, D., Giacomelli, F., Lemaire, C., Aerts, J., Seret, A., Langlois, X., Luxen, A., & Plenevaux, A. (10 August 2011). Use of a beta microprobe system to measure arterial input function in PET via an arteriovenous shunt in rats. EJNMMI Research, 1, 13. doi:10.1186/2191-219X-1-13 |
Geuzaine, A., Bahri, M. A., Warnock, G., Goblet, D., Tirelli, E., Lemaire, C., Seret, A., Salmon, E., Garraux, G., Luxen, A., & Plenevaux, A. (May 2011). Reliability in kinetic modeling of [18F]fallypride binding in the mouse brain: application of test-retest method [Poster presentation]. XII Turku PET symposium, Turku, Finland. |
Garraux, G., Bahri, M. A., Lemaire, C., Degueldre, C., Salmon, E., & KASCHTEN, B. (2011). Brain energization in response to deep brain stimulation of subthalamic nuclei in Parkinson's disease. Journal of Cerebral Blood Flow and Metabolism. doi:10.1038/jcbfm.2011.41 |
Bahri, M. A., Geuzaine, A., Warnock, G., Goblet, D., Tirelli, E., Lemaire, C., Seret, A., Salmon, E., Luxen, A., & Plenevaux, A. (17 January 2011). [18F]fallypride binding in the mouse brain: test-retest and effects of registration [Paper presentation]. Hot Topics in Molecular Imaging 2011 (TOPIM 2011) - The 5th Winter Conference of the European Society for Molecular Imaging, Les Houches, France. |
Balentova, E., Collet, C., Lamande-Langle, S., Chretien, F., Thonon, D., Aerts, J., Lemaire, C., Luxen, A., & Chapleur, Y. (2011). Synthesis and hydrolytic stability of novel 3-[18F]fluoroethoxybis(1-methylethyl)silyl]propanamine-based prosthetic groups. Journal of Fluorine Chemistry, 132 (4), 250-257. doi:10.1016/j.jfluchem.2011.01.011 |
Bastin, C., Feyers, D., Jedidi, H., Bahri, M. A., Degueldre, C., Lemaire, C., Collette, F., & Salmon, E. (2011). The cerebral metabolic correlates of episodic autobiographical memory in amnestic Mild Cognitive Impairment. In Proceedings of the 5th International Conference on Memory (pp. 110). |
Bastin, C., Feyers, D., Jedidi, H., Bahri, M. A., Degueldre, C., Lemaire, C., Collette, F., & Salmon, E. (2011). The cerebral metabolic correlates of episodic autobiographical memory amnestic Mild Cognitive Impairment [Paper presentation]. 5th International Conference on Memory ICOM5. |
Bastin, C., Feyers, D., Jedidi, H., Bahri, M. A., Degueldre, C., Lemaire, C., Collette, F., & Salmon, E. (2011). Episodic autobiographical memory in amnestic mild cognitive impairment: a FDG-PET study [Paper presentation]. 21st Meeting of the European Neurological Society, Lisbonne, Portugal. |
Bastin, C., Kerrouche, N., LEKEU, F., Adam, S., Guillaume, B., Lemaire, C., Aerts, J., D'Ydewalle, G., Collette, F., & SALMON, E. (2011). Neural correlates of controlled memory processes in questionable Alzheimer’s disease. In J. W. Ashford, A. Rosen, M. Adamson, P. Bayley, O. Sabri, A. Furst, S. E. Black, ... M. Weiner (Eds.), Advances in Alzheimer's Disease. Volume 2: Handbook of imaging the Alzheimer brain. Amsterdam, Netherlands: IOS Press. |
collet, C., Lamandé-Langle, S., Balentova, E., Chrétien, F., Thonon, D., Aerts, J., Lemaire, C., Luxen, A., & Chapleur, Y. (2011). Synthesis and hydrolytic stability of novel 3-[18F]fluoroethoxybis(1-methylethyl)silyl]propanaminebased prosthetic groups [Poster presentation]. 19th International Symposium on Radiopharmaceutical Sciences. |
Mercier, F., Paris, J., Kaisin, G., Thonon, D., Flagothier, J., Teller, N., Lemaire, C., & Luxen, A. (2011). General Method for Labeling siRNA by Click Chemistry with Fluorine-18 for the Purpose of PET Imaging. Bioconjugate Chemistry, 22 (1), 108-114. doi:10.1021/bc100263y |
Warnock, G., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). THE EFFECT OF P-GP BLOCKADE ON THE BINDING OF 18F-FALLYPRIDE TO DOPAMINE RECEPTORS IN THE RAT BRAIN [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan. |
Warnock, G., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). Kinetic modelling of 18F-fallypride binding to dopamine receptors – a comparison between beta microprobe and microPET [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan. |
Warnock, G., Dedeurwaardere, S., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). THE EFFECT OF BETA MICROPROBE IMPLANTATION ON THE BLOOD BRAIN BARRIER [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan. |
Warnock, G., Dedeurwaerdere, S., Bahri, M. A., Goblet, D., Lemaire, C., Giacomelli, F., Langlois, X., Luxen, A., & Plenevaux, A. (September 2010). IN VIVO PET IMAGING OF THE EFFECT OF THE NMDA ANTAGONIST MEMANTINE ON GLUCOSE METABOLISM IN THE RODENT BRAIN [Poster presentation]. 2010 World Molecular Imaging Congress, Kyoto, Japan. |
Deville, B., Lemaire, C., Degueldre, C., Salmon, E., & Garraux, G. (08 June 2010). Is posterior cerebral hypometabolism always predicitve of dementia in Parkinson's disease? [Poster presentation]. 15th International Congres of Parkinson's disease and Movement Disorders, Toronto, Canada. |
Bastin, C., Kerrouche N, Lekeu, F., Adam, S., Guillaume B, Lemaire, C., Aerts, J., d'Idewalle G, Collette, F., & Salmon, E. (June 2010). Controlled Memory Processes in Questionable Alzheimer's Disease: A View from Neuroimaging Research. Journal of Alzheimer's Disease, 20 (2), 547-560. doi:10.3233/JAD-2010-1393 |
Kaisin, G., Flagothier, J., Mercier, F., Thonon, D., Paris, J., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (June 2010). Click chemistry : radiolabelling of oligonucleotides with fluorine- 18 for PET [Poster presentation]. FACS XIII - French American Chemical Society, Obernai, France. |
Goblet, D., Thonon, D., Plenevaux, A., Lemaire, C., Defraiteur, C., Wouters, L., Franci, X., & Luxen, A. (30 May 2010). Automated radiosynthesis of [18F]MPPF derivatives for imaging 5-HT1A receptors [Poster presentation]. 5TH European Molecular Imaging Meeting, Warsaw, Poland. |
Aerts, J., Voccia, S., Lemaire, C., Giacomelli, F., Goblet, D., Thonon, D., Plenevaux, A., Warnock, G., & Luxen, A. (2010). Fast production of highly concentrated reactive [18F] fluoride for aliphatic and aromatic nucleophilic radiolabelling. Tetrahedron Letters, 51, 64-66. doi:10.1016/j.tetlet.2009.10.085 |
Bastin, C., Feyers, D., Collette, F., Jedidi, H., Lemaire, C., Bahri, M. A., & Salmon, E. (2010). Anosognosia for personality and impaired self-representation in early stages of Alzheimer’s disease [Paper presentation]. workshop “Metacognition: Where next? », Hull, United Kingdom. |
Garraux, G., Phillips, C., Lemaire, C., Luxen, A., Destee, A., Franck, G., & Salmon, E. (2010). Automatic brain image reading for the differential diagnosis between atypical parkinsonian syndromes & Parkinson's disease. Movement Disorders, 25 (7), 379-S379. |
Lemaire, C., Aerts, J., Voccia, S., Libert, L., Mercier, F., Goblet, D., Plenevaux, A., & Luxen, A. (2010). Fast Production of Highly Reactive No-Carrier-Added [18F]Fluoride for the Labeling of Radiopharmaceuticals. Angewandte Chemie International Edition, 49, 1-5. doi:10.1002/anie.200906341 |
Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (October 2009). DISPLACEMENT OF 18F-FALLYPRIDE BINDING WITH HALOPERIDOL IN A WITHIN-SUBJECT DESIGN USING A BETA MICROPROBE. Journal of Cerebral Blood Flow and Metabolism, 29 (S1), 352-S353. |
Warnock, G., Lemaire, C., Langlois, X., Luxen, A., & Plenevaux, A. (October 2009). Accurate measurement of arterial input function during FDG PET using a beta microprobe. Journal of Cerebral Blood Flow and Metabolism, 29 (S1), 339-S339. |
Lemaire, C., Voccia, S., Aerts, J., Luxen, A., Morelle, J.-L., & Phillipart, G. (01 August 2009). Method for the direct elution of reactive 18F fluoride from an anion exchange resin in an organic medium suitable for radiolabeling without any evaporation step by the use of strong organic bases. |
Bahri, M. A., Warnock, G., Goblet, D., Lemaire, C., Langlois, X., Seret, A., Luxen, A., & Plenevaux, A. (12 July 2009). Comparaison of reference tissue model versus two compartement model with input function for [18F]Fallypride modelling. A combined microPET-Beta microprobe study in rat. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 108. |
Aerts, J., Lemaire, C., Plenevaux, A., & Luxen, A. (July 2009). Are Ionic Liquid Useful for Fluorine-18 Labeling? Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 193. |
Aerts, J., Voccia, S., Lemaire, C., Giacomelli, F., Goblet, D., Thonon, D., Plenevaux, A., & Luxen, A. (July 2009). Modified Non-Ionic Solid Supports: a Way to High Activity Fluorine-18 Radiochemistry in Microfluidic Devices. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 12. |
Aerts, J., Voccia, S., Lemaire, C., Thonon, D., Plenevaux, A., & Luxen, A. (July 2009). Tertiary Alcohols to Avoid Evaporation in Fluorine-18 Labeling. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 204. |
Lemaire, C., Aerts, J., Voccia, S., Plenevaux, A., & Luxen, A. (July 2009). Use of Organic Bases for 18F-Fluoride Anion Exchange Elution avoiding the Classical Azeotropic drying Step Before Labeling. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 198. |
Lemaire, C., Libert, L., Plenevaux, A., & Luxen, A. (July 2009). Fast and Reliable Method for the Preparation of Various [18F]Fluorobenzyl Halides. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 178. |
Libert, L., Lemaire, C., Denoël, T., Plenevaux, A., Aerts, J., & Luxen, A. (July 2009). New Improvements in the Enantioselective Synthesis of 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 196. |
Libert, L., Lemaire, C., Wouters, L., Plenevaux, A., Franci, X., & Luxen, A. (July 2009). Large Scale Preparation of [18]Fluoromethoxybenzyl Bromides, Key Precursors for 2-[18F]Fluoro-L-Tyrosine and 6-[18F]Fluoro-L-Dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 292. |
Thonon, D., Paris, J., Kech, C., Lemaire, C., & Luxen, A. (2009). PEPTIDE CLICK LABELLING WITH 1-(AZIDOMETHYL)-4-[18F]-FLUOROBENZENE AND REFERENCE COMPOUNDS SYNTHESIS ON SOLID SUPPORT. In Journal of Labelled Compounds and Radiopharmaceuticals (pp. 26). John Wiley & Sons Ltd. |
Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). USE OF A BETA MICROPROBE SYSTEM AS AN AFFORDABLE TRANSLATIONAL TOOL COMPARED TO PET – EXAMPLES USING FDG AND 18F-FALLYPRIDE BINDING. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 55. |
Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). TIME-DEPENDENT PREFERENTIAL IN VIVO D2 OCCUPANCY BY AMISULPRIDE IN THE MEDIAL STRIATUM – CONTINUOUS MEASUREMENT USING A BETA MICROPROBE SYSTEM. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 105. |
Warnock, G., Goblet, D., Lemaire, C., Giacomelli, F., Bahri, M. A., Langlois, X., Luxen, A., & Plenevaux, A. (July 2009). THE USEFULNESS OF AN ARTERIOVENOUS SHUNT COMBINED WITH A BETA MICROPROBE FOR THE MEASUREMENT OF INPUT FUNCTION IN RATS. Journal of Labelled Compounds and Radiopharmaceuticals, 52 (S1), 106. |
Flagothier, J., Mercier, F., Kaisin, G., Thonon, D., Lemaire, C., & Luxen, A. (29 May 2009). Universal solid support synthesis of modified oligonucleotides labeled by click chemistry for PET studies [Poster presentation]. 4th European Molecular Imaging Meeting of the ESMI, Barcelona, Spain. |
Thonon, D., Paris, J., Kech, C., Lemaire, C., & Luxen, A. (26 March 2009). New Strategy for the Preparation of Clickable Peptides and Labeling with 1-(Azidomethyl)-4-[18F]-fluorobenzene for PET. Bioconjugate Chemistry, 20 (4), 817-823. doi:10.1021/bc800544p |
Kaisin, G., Flagothier, J., Mercier, F., Thonon, D., Paris, J., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (18 March 2009). Click chemistry : radiolabelling of oligonucleotides with fluorine-18 for PET imaging [Poster presentation]. Learning Organic Synthesis Tremendously (LOST II), Namur, Belgium. |
Flagothier, J., Mercier, F., Kaisin, G., Lemaire, C., Plenevaux, A., & Luxen, A. (21 January 2009). Synthesis of an universal linker to label oligonucleotides via Click Chemistry [Poster presentation]. Journées rencontres des jeunes chimistes, Wépion, Belgium. |
Bastin, C., Adam, S., LEKEU, F., Guillaume, B., Lemaire, C., Aerts, J., Collette, F., & Salmon, E. (2009). Combiner les mesures métaboliques cérébrales et neuropsychologiques permet une meilleure prédiction de la conversion vers une maladie d’Alzheimer chez les patients MCI. Revue Neurologique, 165, 80. |
Bastin, C., Leclercq, Y., Collette, F., Lemaire, C., Aerts, J., Perani, D., Holthoff, V., Beuthien-Baumann, B., Sorbi, S., Herholz, K., & Salmon, E. (2009). Multivariate analysis of cognitive profiles in Alzheimer's disease. In Proceedings of the 8th bi-annual Meeting of the Belgian Society for Neuroscience (pp. 52). |
Salmon, E., Kerrouche, N., Perani, D., Lekeu, F., Holthoff, V., Beuthien-Baumann, B., Sorbi, S., Lemaire, C., Collette, F., & Herholz, K. (2009). On the multivariate nature of brain metabolic impairment in Alzheimer’s disease. Neurobiology of Aging, 30, 186–197. doi:10.1016/j.neurobiolaging.2007.06.010 |
Aerts, J., Plenevaux, A., Lemaire, C., Giacomelli, F., Warnock, G., Phillips, C., & Luxen, A. (07 November 2008). Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in rats. BMC Medical Physics, 8, 4. doi:10.1186/1756-6649-8-4 |
Voccia, S., Aerts, J., Lemaire, C., Luxen, A., Morelle, J.-L., & Philippart, G. (30 October 2008). Method for the preparation of reactive [18F]fluoride. |
Goblet, D., Lemaire, C., Giacomelli, F., Plenevaux, A., Warnock, G., Franci, X., Wouters, L., & Luxen, A. (September 2008). Automated synthesis of [18F]fallypride for imaging dopamine D2 receptors [Poster presentation]. World Molecular Imaging Congress, Nice, France. |
Aerts, J., Lemaire, C., Lignon, S., Luxen, A., Morelle, J.-L., Philippart, G., & Voccia, S. (28 August 2008). Methof for the elution of 18F fluoride trapped on an anion-exchange phase in a form suitable for efficient radiolabelling without any evaporation step. |
Thonon, D., Flagothier, J., Paris, J., Mercier, F., Kaisin, G., Kech, C., Lemaire, C., Plenevaux, A., & Luxen, A. (August 2008). 18F LABELING OF BIOMOLECULES USING CLICK CHEMISTRY FOR PET APPLICATIONS : SYNTHETIC DEVELOPMENTS. Drugs of the Future, 33 (A), 235. |
Paris, J., Thonon, D., kech, C., Lemaire, C., & Luxen, A. (03 July 2008). Click chemistry for 18F labelling of bioactive compounds [Poster presentation]. 44èmes rencontres internationales de chimie thérapeutique : interfacing chemical biology, natural products and drug discovery, Angers, France. |
Bastin, C., Kerrouche, N., LEKEU, F., Adam, S., Guillaume, B., Lemaire, C., Aerts, J., d'Ydewalle, G., Collette, F., & Salmon, E. (2008). Metabolic correlates of controlled memory processes in very early Alzheimer’s disease and stable questionable Alzheimer’s disease [Paper presentation]. Recollection workshop, Tours, France. |
Bastin, C., Kerrouche, N., Lekeu, F., Adam, S., Guillaume, B., Lemaire, C., Aerts, J., & Salmon, E. (2008). Les corrélats métaboliques des processus contrôlés en mémoire dans la maladie d'Alzheimer très débutante. In A.-M. Ergis, N. Fiori, L. Chaby, C. Belin, L. Fabre, ... D. Gandini (Eds.), Xème colloque international sur le vieillissement cognitif (pp. 93). Paris, France: Publibook. |
Lacan, G., Plenevaux, A., Rubins, D. J., Way, B. M., Defraiteur, C., Lemaire, C., Aerts, J., Luxen, A., Cherry, S. R., & Melega, W. P. (2008). Cyclosporine, a P-glycoprotein modulator, increases [18F]MPPF uptake in rat brain and peripheral tissues: microPET and ex vivo studies. European Journal of Nuclear Medicine and Molecular Imaging, 35 (12), 2256-66. doi:10.1007/s00259-008-0832-z |
Thonon, D., Kech, C., Lemaire, C., & Luxen, A. (2008). Click Chemistry Based Labeling of Biomolecules with 18F: a New Method to Produce PET Molecular Tracers [Poster presentation]. Biomedica Life Science Summit. |
Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & Hustinx, R. (May 2007). PET/CT of skull base meningiomas using 2-F-18-fluoro-L-tyrosine: Initial report. Journal of Nuclear Medicine, 48 (5), 720-725. doi:10.2967/jnumed.106.038216 |
Mercier, F., Zervosen, A., Lemaire, C., Plenevaux, A., Joris, B., & Luxen, A. (22 March 2007). Synthesis of anhydro-muramic acid derivatives as substrates for MurNAc amidase [Poster presentation]. Biomedica, Aachen, Germany. |
Bastin, C., LEKEU, F., Collette, F., Feyers, D., Lemaire, C., Adam, S., & Salmon, E. (2007). Cerebral metabolic correlates of controlled memory processes in questionable Alzheimer’s disease [Paper presentation]. First Consortium Meeting IAP/IUAP/PAI P6/29. |
Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 2-18F-fluoro-L-tyrosine : Initial report. Journal of Nuclear Medicine, 48 (SUPPL), 11. |
Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (July 2006). Radiochemical synthesis and tissue distribution of p-[F-18]DMPPF, a new 5-HT1A ligand for PET, in rats. Nuclear Medicine and Biology, 33 (5), 667-675. doi:10.1016/j.nucmedbio.2006.03.010 |
Mercier, F., Lemaire, C., Plenevaux, A., Nguyen-Distèche, M., Zervosen, A., Joris, B., & Luxen, A. (17 May 2006). Synthesis of anhydro-muramic acid derivatives as substrates for MurNAc amidase [Poster presentation]. Bioforum 2006. |
Salmon, E., Kerrouche, N., Herholz, K., Perani, D., Holthoff, V., Beuthien-Baumann, B., Degueldre, C., Lemaire, C., Luxen, A., Baron, J.-C., Collette, F., & Garraux, G. (15 April 2006). Decomposition of metabolic brain clusters in the frontal variant of frontotemporal dementia. NeuroImage, 30 (3), 871-878. doi:10.1016/j.neuroimage.2005.10.016 |
Giacomelli, F., Luxen, A., Lemaire, C., & Plenevaux, A. (03 February 2006). DEVELOPPEMENT D'INHIBITEURS SELECTIFS DE LA TRYPTOPHANE HYDROXYLASE [Paper presentation]. 7 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium. |
Laique, S., Egrise, D., Monclus, M., Schmitz, F., Garcia, C., Lemaire, C., Luxen, A., & Goldman, S. (2006). L-amino acid load to enhance PET differentiation between tumor and inflammation: an in vitro study on (18)F-FET uptake. Contrast Media and Molecular Imaging, 1 (5), 212-20. doi:10.1002/cmmi.107 |
Peters, F., Perani, D., Herholz, K., Holthoff, V., Beuthien-Baumann, B., Sorbi, S., Pupi, A., Degueldre, C., Lemaire, C., Collette, F., & Salmon, E. (2006). Orbitofrontal dysfunction related to both apathy and disinhibition in frontotemporal dementia. Dementia and Geriatric Cognitive Disorders, 21 (5-6), 373-379. doi:10.1159/000091898 |
Mercier, F., Lemaire, C., Plenevaux, A., Nguyen, M., Zervosen, A., Joris, B., & Luxen, A. (10 October 2005). Synthesis of anhydro-muranic acid derivatives as substrates for MurNAc amidase [Poster presentation]. 9. International SFB-Symposium. Asymmetric Synthesis with Chemical and Biological Methods, Aachen, Germany. |
Teller, N., Lemaire, C., Plenevaux, A., Nguyen, M., Zervosen, A., Joris, B., & Luxen, A. (10 October 2005). Synthesis of protected meso-diaminopimelic acid [Poster presentation]. 9. International SFB-Symposium. Asymmetric Synthesis with Chemical and Biological Methods, Aachen, Germany. |
Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (2005). Radiochemical Synthesis of OCH2F-[18F]MPPF a New Analogue of p-[18F]MPPF for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 102. |
Defraiteur, C., Lemaire, C., Luxen, A., & Plenevaux, A. (2005). Ex Vivo Evaluation of p-[18F]D-MPPF for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 75. |
Kech, C., Lemaire, C., Brichard, L., Plenevaux, A., & Luxen, A. (2005). New Methods For Halogenation of [18F]Fluorinated Benzyl Derivatives. Journal of Labelled Compounds and Radiopharmaceuticals, 48, 30. |
Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (17 November 2004). Mise au point de sondes pour l'étude du système sérotoninergique par Tomographie à Emission de Positons (TEP) [Poster presentation]. The 2004 Lilly European Distinguished Lectureship, Namur, Belgium. |
Lemaire, C., Gillet, S., Guillouet, S., Plenevaux, A., Aerts, J., & Luxen, A. (2004). Highly enantioselective synthesis of no-carrier-added 6-[18F]Fluoro-L-dopa by chiral phase-transfer alkylation. European Journal of Organic Chemistry, (13), 2899-2904. doi:10.1002/ejoc.200400059 |
Defraiteur, C., Muroni, S., Lemaire, C., Luxen, A., & Plenevaux, A. (2004). Tissue distribution and metabolism of D-p-[18F]MPPF in rats [Paper presentation]. Society of Nuclear Medicine, 51th Annual Meeting, Philadelphia, United States. |
Kaschten, B., Lemaire, C., Luxen, A., Stevenaert, A., & HUSTINX, R. (2004). 18F-tyrosine PET in Neurooncology : an alternative to 11C-methionine. Journal of Nuclear Medicine, 45 (SUPPL), 264. |
Defraiteur, C., Plenevaux, A., Lemaire, C., & Luxen, A. (August 2003). Radiochemical Synthesis of p-[18F]Desmethyl-MPPF (p-[18F]D-MPPF) for the Study of 5-HT1A Receptors. Journal of Labelled Compounds and Radiopharmaceuticals, 46 (S1), 157. |
Defraiteur, C., Plenevaux, A., Lemaire, C., & Luxen, A. (13 June 2003). Radiosynthèses d'antagonistes des récepteurs 5-HT1A [Poster presentation]. 5ème Rencontres Franco-Belges de chimie organique, Houffalize, Belgium. |
Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (13 June 2003). Mise au point de sondes pour l'étude du système sérotoninergique par tomographie à émission de positons (TEP) [Poster presentation]. 5 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium. |
Otabashi, M., Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (13 June 2003). Radiosynthèse de dérivés du 7-[18F]fluoroindole [Poster presentation]. 5 èmes Rencontres Franco-Belges de chimie organique, Houffalize, Belgium. |
Hustinx, R., Lemaire, C., Jerusalem, G., Moreau, P., Cataldo, D., Duysinx, B., Aerts, J., Fassotte, M.-F., Foidart, J., & Luxen, A. (April 2003). Whole-body tumor imaging using PET and 2-18F-fluoro-l-tyrosine: Preliminary evaluation and comparison with 18F-FDG. Journal of Nuclear Medicine, 44 (4), 533-539. |
Brichard, L., Del Fiore, G., Lemaire, C., Plenevaux, A., & Luxen, A. (2003). Simple device for the radiosynthesis of [carbonyl-11C]amides, esters and ketones using carbon-11 monoxide. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 74. |
Lekeu, F., Van der Linden, M., Degueldre, C., Lemaire, C., Luxen, A., Franck, G., Moonen, G., & Salmon, E. (January 2003). Effects of Alzheimer's disease on the recognition of novel versus familiar words : Neuropsychological and clinico-metabolic data. Neuropsychology, 17 (1), 143-154. doi:10.1037/0894-4105.17.1.143 |
Otabashi, M., Giacomelli, F., Lemaire, C., Plenevaux, A., & Luxen, A. (2003). Radiosynthesis of 7-[18F]fluoroindole derivatives. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 223. |
Wouters, L., Lemaire, C., Plenevaux, A., Ooi, T., Maruoka, K., & Luxen, A. (2003). Synthesis of [18F]fluorinated a-methyl-a-amino acids by phase transfer catalysis for potential PET application. Journal of Labelled Compounds and Radiopharmaceuticals, 46, 206. |
Mosdzianowski, C., Lemaire, C., Simoens, F., Aerts, J., Morelle, J. L., & Luxen, A. (June 2002). Epimerization study on [18F]FDG produced by an alkaline hydrolysis on solid support under stringent conditions. Applied Radiation and Isotopes, 56 (6), 871-875. doi:10.1016/S0969-8043(01)00145-2 |
HUSTINX, R., Lemaire, C., JERUSALEM, G., MOREAU, P., Cataldo, D., DUYSINX, B., Aerts, J., & Luxen, A. (2002). 18F-fluoro-L-tyrosine : a potential tracer for whole-body tumor imaging with PET. Journal of Nuclear Medicine, 43, 77. |
Lemaire, C., Damhaut, P., Lauricella, B., Mosdzianowski, C., Morelle, J. L., Monclus, M., Van Naemen, J., Mulleneers, E., Aerts, J., Plenevaux, A., Brihaye, C., & Luxen, A. (2002). Fast F-18 FDG synthesis by alkaline hydrolysis on a low polarity solid phase supports. Journal of Labelled Compounds and Radiopharmaceuticals, 45 (5), 435-447. doi:10.1002/jlcr.572 |
Plenevaux, A., Lacan, G., Defraiteur, C., Gillet, S., Way, B. M., Rubin, D. J., Lemaire, C., Aerts, J., Melega, W. P., & Luxen, A. (2002). Influence of P-glycoprotein on the tissue distribution in rats of the 5-HT1A antagonist p-[18F]MPPF [Paper presentation]. Society for Neuroscience, 32nd annual meeting, Orlando, United States. |
Peigneux, P., Salmon, E., Garraux, G., Laureys, S., Willems, S., Dujardin, K., Degueldre, C., Lemaire, C., Luxen, A., Moonen, G., Franck, G., Destee, A., & Van der Linden, M. (09 October 2001). Neural and cognitive bases of upper limb apraxia in corticobasal degeneration. Neurology, 57 (7), 1259-1268. doi:10.1212/WNL.57.7.1259 |
Costes, N., Le Bars, D., Merlet, I., Zimmer, L., Berthier, V., Lionnet, M., Vighi, C., Lavenne, F., Delforge, J., Plenevaux, A., Lemaire, C., Cinotti, L., Luxen, A., & Pujol, J.-F. (2001). Modeling p-18FMPPF pet kinetics for the detremination of local 5-HT1A receptor concentration. Journal of Nuclear Medicine, 42 (S1), 209. |
Laureys, S., Faymonville, M.-E., Berre, J., Antoine, S., Damas, P., Van Bogaert, P., Lambermont, B., Damas, F., Janssens, N., Degueldre, C., Lemaire, C., Del Fiore, G., Aerts, J., Ebinger, G., Luxen, A., Moonen, G., Lamy, M., Goldrnan, S., & Maquet, P. (2001). Etudes par tomographie à émission de positons chez des patients en coma, en état végétatif ou de conscience minimale, en «locked-in syndrome» et en mort cérébrale. In L'évaluation neurophysiologique des comas, de la mort encéphalique et des états végétatifs (pp. 367-376). |
Lemaire, C., Gillet, S., Ooi, T., Kameda, M., Takeuchi, M., Maruoka, K., Plenevaux, A., & Luxen, A. (2001). Enantioselective synthesis of 2-[18F]fluoro-L-Tyrosine by catalytic phase-transfer alkylation. Journal of Labelled Compounds and Radiopharmaceuticals, 44, 857. |
Garraux, G., Salmon, E., Peigneux, P., Kreisler, A., Degueldre, C., Lemaire, C., Destee, A., & Franck, G. (September 2000). Voxel-based distribution of metabolic impairment in corticobasal degeneration. Movement Disorders, 15 (5), 894-904. doi:10.1002/1531-8257(200009)15:5<894::AID-MDS1021>3.0.CO;2-S |
Plenevaux, A., Lemaire, C., Aerts, J., Lacan, G., Rubins, D., Melega, W. P., Brihaye, C., Degueldre, C., Fuchs, S., Salmon, E., Maquet, P., Laureys, S., Damhaut, P., Weissmann, D., Le Bars, D., Pujol, J.-F., & Luxen, A. (July 2000). [(18)F]p-MPPF: A radiolabeled antagonist for the study of 5-HT(1A) receptors with PET. Nuclear Medicine and Biology, 27 (5), 467-71. doi:10.1016/S0969-8051(00)00113-X |
Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., & Luxen, A. (12 May 2000). Synthèse du 6-fluoro-a-méthyl-L-tryptophane et de ses principaux métabolites [Poster presentation]. 2èmes Rencontres Franco-Belges de chimie organique, Pont-à-Mousson, France. |
Peigneux, P., Salmon, E., Garraux, G., Willems, S., Lemaire, C., Luxen, A., Franck, G., Destée, A., & Van der Linden, M. (2000). Cognitive neuropsychological and brain imaging investigation of apraxia in corticobasal degeneration. NeuroImage. |
Plenevaux, A., Weissmann, D., Aerts, J., Lemaire, C., Brihaye, C., Degueldre, C., Le Bars, D., Comar, D., Pujol, J. F., & Luxen, A. (2000). Tissue distribution, autoradiography, and metabolism of 4-(2'-methoxyphenyl)-1-[2' -[N-2"-pyridinyl)-p-[(18)F]fluorobenzamido]ethyl]piperazine (p-[(18)F]MPPF), a new serotonin 5-HT(1A) antagonist for positron emission tomography: An In vivo study in rats. Journal of Neurochemistry, 75 (2), 803-11. doi:10.1046/j.1471-4159.2000.0750803.x |
Salmon, E., Collette, F., Degueldre, C., Lemaire, C., & Franck, G. (2000). Voxel-based analysis of confounding effects of age and dementia severity on cerebral metabolism in Alzheimer's disease. Human Brain Mapping, 10 (1), 39-48. doi:10.1002/(SICI)1097-0193(200005)10:1<39::AID-HBM50>3.0.CO;2-B |
Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., & Franck, G. (15 October 1999). Medial temporal lobe metabolic impairment in dementia associated with motor neuron disease. Journal of the Neurological Sciences, 168 (2), 145-150. doi:10.1016/S0022-510X(99)00188-4 |
Garraux, G., Salmon, E., Degueldre, C., Lemaire, C., Laureys, S., & Franck, G. (August 1999). Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal demential. NeuroImage, 10 (2), 149-162. doi:10.1006/nimg.1999.0463 |
Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., & Luxen, A. (03 May 1999). Synthèse du 6-fluoro-a-méthyl-L-tryptophane et d'un de ses métabolites [Poster presentation]. 1 ères Rencontres Franco-Belges de chimie organique, Houffalize, Belgium. |
Damhaut, P., Plenevaux, A., Lemaire, C., Aerts, J., Biver, F., Monclus, M., Luxen, A., & Goldman, S. (1999). In vivo studies of p-[18F]MPPF metabolites in human. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 661. |
Fuchs, S., Plenevaux, A., Degueldre, C., Lemaire, C., Aerts, J., Laureys, S., Salmon, E., Maquet, P., Le Bars, D., Pujol, J.-F., & Luxen, A. (1999). 5-HT1A receptor distribution in the human brain: preliminary PET data with p-[18F]MPPF. Society for Neuroscience / Abstracts, 25, 1462. |
Lambin, D., Tadino, V., Olynyk, C., Lemaire, C., Plenevaux, A., Pujol, J.-F., & Luxen, A. (1999). Synthesis and in vivo evaluation of 6-fluoro-a-methyl-L-tryptophan. American Chemical Society / Abstracts, 256. |
Laureys, S., Lemaire, C., Maquet, P., Phillips, C., & Franck, G. (1999). Cerebral metabolism during vegetative state and after recovery to consciousness. Journal of Neurology, Neurosurgery and Psychiatry, 67 (1), 121-122. doi:10.1136/jnnp.67.1.121 |
Laureys, S., Salmon, E., Garraux, G., Peigneux, P., Lemaire, C., Degueldre, C., & Franck, G. (1999). Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. Journal of Neurology, 246 (12), 1151-8. doi:10.1007/s004150050534 |
Le Bars, D., Ginovart, N., Hassoun, W., Weissmann, D., Lemaire, C., Plenevaux, A., Aerts, J., Luxen, A., Pujol, J.-F., & Leviel, V. (1999). p-[18F]MPPF, a fluoro analog of WAY-100635 for visualisation of 5-HT1A receptors in cat. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 395. |
Lemaire, C., Guillouet, S., Plenevaux, A., Brihaye, C., Aerts, J., & Luxen, A. (1999). The synthesis of 6-[18F]fluoro-L-dopa by chiral catalytic phase-transfer alkylation. Journal of Labelled Compounds and Radiopharmaceuticals, 42, 113. |
Lemaire, C., Plenevaux, A., Aerts, J., Del Fiore, G., Brihaye, C., Le Bars, D., Comar, D., & Luxen, A. (1999). Solid phase extraction : An alternative to the use of rotary evaporators for solvent removal in the rapid formulation of PET radiopharmaceuticals. Journal of Labelled Compounds and Radiopharmaceuticals, 42 (1), 63-75. doi:10.1002/(SICI)1099-1344(199901)42:1<63::AID-JLCR167>3.0.CO;2-R |
Plenevaux, A., Lemaire, C., Salmon, E., Laureys, S., Fuchs, S., Maquet, P., Degueldre, C., Aerts, J., Brihaye, C., Damhaut, P., Biver, F., Goldman, S., Le Bars, D., Ginovart, N., Cinotti, L., Pujol, J.-F., & Luxen, A. (1999). 5-HT1A Receptors visualization with p-[18F]MPPF in healthy volunteers [Paper presentation]. XIIIth International Symposium on Radiopharmaceutical Chemistry, Saint Louis, United States. |
Plenevaux, A., Weissmann, D., Lemaire, C., Aerts, J., Comar, D., Le Bars, D., Pujol, J.-F., & Luxen, A. (1999). p-[18F]MPPF, 5-HT1A antagonist: comparison to [3H]8-OH-DPAT with autoradiography [Paper presentation]. Society for Neuroscience, 29th annual meeting, Miami, United States. |
Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (1998). Metabolism of no-carrier-added 2-[18F]fluoro-L-tyrosine in free mooving rats. Society for Neuroscience / Abstracts, 24, 428. |
Le Bars, D., Lemaire, C., Ginovart, N., Plenevaux, A., Aerts, J., Brihaye, C., Hassoun, W., Leviel, V., Mekhsian, P., Weissmann, D., Pujol, J. F., Luxen, A., & Comar, D. (1998). High-yield radiosynthesis and preliminary in vivo evaluation of p-[18F]MPPF, a fluoro analog of WAY-100635. Nuclear Medicine and Biology, 25 (4), 343-50. doi:10.1016/S0969-8051(97)00229-1 |
Lemaire, C., Damhaut, P., Monclus, M., Van Namen, J., Mulleneers, E., Morelle, J.-L., Luxen, A., & Lauricella, B. (13 November 1997). Method and device for synthesizing labeled compounds. |
Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (29 May 1997). Métabolisme de la 6-fluoro-L-tyrosine chez le rat [Poster presentation]. Journées franco-belges de pharmacochimie. Onzièmes journées. De la conception à la réalisation en pharmacochimie. |
Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (29 May 1997). Métabolisme du p-[18]MPPF (antagoniste 5-HT1A) chez le rat [Poster presentation]. Journées franco-belges de pharmacochimie. Onzièmes journées. De la conception à la réalisation en pharmacochimie, Bruxelles, Belgium. |
Ginovart, N., Le Bars, D., Lemaire, C., Plenevaux, A., Aerts, J., Pujol, J.-F., Weissmann, D., Mekhsian, P., Luxen, A., Comar, D., & Leviel, V. (25 May 1997). Le p-[18F]MPPF: un nouveau ligand pour l'étude par TEP des récepteurs 5-HT1A [Poster presentation]. 3ème Colloque de la Société des Neurosciences, Bordeaux, France. |
Aerts, J., Plenevaux, A., Lemaire, C., Brihaye, C., & Luxen, A. (1997). Metabolism of no carrier added 2-[18F]fluoro-L-tyrosine in free moving rats. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 145. |
Damhaut, P., Lemaire, C., Plenevaux, A., Brihaye, C., Christiaens, L., & Comar, D. (1997). No-carrier-added asymmetric synthesis of alpha-methyl-alpha-amino acids labelled with fluorine-18. Tetrahedron, 53 (16), 5785-5796. doi:10.1016/S0040-4020(97)00265-2 |
Lambin, D., Lemaire, C., Plenevaux, A., Damhaut, P., & Luxen, A. (1997). Synthesis of a fluorinated analogue of L-threo-3-(3,4-dihydroxyphenyl)serine: 6-fluoro-L-threo-DOPS. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 17. |
Le Bars, D., Ginovart, N., Lemaire, C., Plenevaux, A., Aerts, J., Pujol, J.-F., Mekhsian, P., Weissmann, D., Leviel, V., Luxen, A., & Comar, D. (1997). Microwave improved synthesis of p-[18F]MPPF, 5-HT1A antagonist and PET sudies on cat brain. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 238. |
Le Bars, D., Lemaire, C., Plenevaux, A., Aerts, J., Leviel, V., Pujol, J.-F., Luxen, A., & Comar, D. (1997). High yield radiosynthesis of p-[F-18]MPPF, 5-HT1A antagonist, and PET studies in cat brain. Journal of Nuclear Medicine, 38, 56. |
Lemaire, C., Damhaut, P., Lauricella, B., Morelle, J.-L., Monclus, M., Van Naemen, J., Mulleneers, E., Aerts, J., Plenevaux, A., Brihaye, C., & Luxen, A. (1997). Synthesis of [18F]FDG with alkaline hydrolysis on a low polarity solid phase support. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 256. |
Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Tissue distribution, autoradiography and metabolism in rats of p-[18F]MPPF: 5-HT1A antagonist. Journal of Labelled Compounds and Radiopharmaceuticals, 40, 148. |
Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Evaluation of p-[F-18]MPPF, 5-HT1A antagonist, in rats: tissue distribution, autoradiography and metabolism. Journal of Nuclear Medicine, 38, 56. |
Plenevaux, A., Aerts, J., Lemaire, C., Brihaye, C., Le Bars, D., Mekhsian, P., Weissmann, D., Pujol, J.-F., Comar, D., & Luxen, A. (1997). Evaluation of p-[18F]MPPF, 5-HT1A antagonist, a potential radiopharmaceutical for PET: tissue distribution, autoradiography and metabolism in rats. Society for Neuroscience / Abstracts, 23, 129. |
Salmon, E., Grégoire, M. C., Delfiore, G., Lemaire, C., Degueldre, C., Franck, G., & Comar, D. (May 1996). Combined study of cerebral glucose metabolism and [11C] methionine accumulation in probable Alzheimer's disease using positron emission tomography. Journal of Cerebral Blood Flow and Metabolism, 16 (3), 399-408. doi:10.1097/00004647-199605000-00006 |
Al-Darwich, M. J., Plenevaux, A., Lemaire, C., De Fiore, G., Christiaens, L., Comar, D., & Luxen, A. (1996). Enantioselective syntheses of no-carrier-added (nca) (S)-4-chloro-2 F-18 fluorophenylalanine and (S)-(alpha-methyl)-4-chloro-2 F-18 fluorophenylalanine. Journal of Fluorine Chemistry, 80 (2), 117-124. doi:10.1016/S0022-1139(96)03488-4 |
Del Fiore, G., Schmitz, F., Plenevaux, A., Lemaire, C., Aerts, J., & Luxen, A. (1995). Fast routine production of L-[11C-methyl]methionine with Al2O3/KF in a disposable unit. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 746. |
Lemaire, C. (1995). Fluorine-18 labeling of radiopharmaceuticals for PET studies: main aspects and problems encountered in chemical syntheses. In A. Emran (Ed.), Chemists' Views of Imaging Centers (pp. 367-382). New York, United States - New York: Plenum Press. |
Lemaire, C., Plenevaux, A., Del Fiore, G., Aerts, J., Luxen, A., Le Bars, D., & Comar, D. (1995). Sep Pak as alternative to rotary evaporators for radiopharmaceutical formulations. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 723. |
Plenevaux, A., Lemaire, C., Aerts, J., Del Fiore, G., & Luxen, A. (1995). Fast quality control of short-lived radiopharmaceutical compounds with a photodiode array detector. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 695. |
Sadzot, B., Lemaire, C., Maquet, P., Salmon, E., Plenevaux, A., Degueldre, C., Hermanne, J. P., Guillaume, M., Cantineau, R., & Comar, D. (1995). Serotonin 5HT2 receptor imaging in the human brain using positron emission tomography and a new radioligand, [18F]altanserin: results in young normal controls. Journal of Cerebral Blood Flow and Metabolism, 15 (5), 787-97. doi:10.1038/jcbfm.1995.99 |
Salmon, E., Lemaire, C., Degueldre, C., Plenevaux, A., Sadzot, B., Comar, D., & Franck, G. (1995). Glucose hypometabolism in Alzheimer's disease is not related to loss of cortical interneurons bearing 5HT2 receptors. Acta Neurologica Belgica, 95, 50. |
Schmitz, F., Del Fiore, G., Plenevaux, A., Lemaire, C., Aerts, J., & Luxen, A. (1995). [1-11C]Bromoethane: an alternative to the use of [1-11C]iodoethane. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 111. |
Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., Aerts, J., & Luxen, A. (1995). S-, N- and O-[11C]methylations of a Nor precursor adsorbed on Al2O3/KF. Journal of Labelled Compounds and Radiopharmaceuticals, 37, 106. |
Schmitz, F., Plenevaux, A., Del-Fiore, G., Lemaire, C., Comar, D., & Luxen, A. (1995). Fast Routine Production of L-[11C-methyl]methionine with Al2O3KF. Applied Radiation and Isotopes, 46 (9), 893-897. doi:10.1016/0969-8043(95)00181-C |
Abraini, J. H., ANSSEAU, M., Martinez, E., Burner, H., Wauthy, J., & Lemaire, C. (1994). Development of anxiety symptoms during a deep diving experiment. Anxiety, 1 (5), 237-241. doi:10.1002/anxi.3070010509 |
Al-Darwich, M. J., Plenevaux, A., Lemaire, C., Comar, D., & Luxen, A. (1994). Enantioselective synhteses of n.c.a. L-2-[18F]fluoro-4-chlorophenylalanine and of L-(a-methyl)-2-[18F]fluoro-4-chlorophenylalanine. Journal of Nuclear Medicine, 35, 251. |
Brihaye, C., Lemaire, C., Damhaut, P., Plenevaux, A., & Comar, D. (1994). Robot-assisted synthesis of [18F]altanserin, 4-[18F]fluorotropapride, 6-[18F]fluoro-L-dopa and 2-[18F]fluoro-L-tyrosine. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 160. |
Cantineau, R., Guillaume, M., Damhaut, P., Lemaire, C., Plenevaux, A., Gauthier, F., Pourrias, B., & Christiaens, L. (1994). Synthesis and biodistribution of [5-131I]iodotropapride: a potential D2 dopamine receptor imaging agent. Nuclear Medicine and Biology, 21 (2), 255-62. doi:10.1016/0969-8051(94)90017-5 |
Damhaut, P., Lemaire, C., Plenevaux, A., Christiaens, L., & Comar, D. (1994). N.C.A. asymmetric syntheses of a-methyl and b-hydroxy a-amino acid labelled with fluorine-18 for probing enzymatic function. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 178. |
Lemaire, C., Damhaut, P., Plenevaux, A., & Comar, D. (1994). Enantioselective synthesis of 6-[fluorine-18]-fluoro-L-dopa from no-carrier-added fluorine-18-fluoride. Journal of Nuclear Medicine, 35 (12), 1996-2002. |
Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Del Fiore, G., & Comar, D. (1994). Enantioselective syntheses of n.c.a. L-(a-methyl)-[b-11C]-4-chlorophenylalanine and L-(a-[11C]methyl-tryptophan. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 108. |
Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Delfiore, G., & Comar, D. (1994). ENANTIOSELECTIVE SYNTHESES OF NCA (S)-L-[BETA-C-11]-4-CHLOROPHENYLALANINE AND (S)-L-(ALPHA-METHYL)-[BETA-C-11]-4-CHLOROPHENYLALANINE. Applied Radiation and Isotopes, 45 (3), 361-369. doi:10.1016/0969-8043(94)90051-5 |
Plenevaux, A., Lemaire, C., Delfiore, G., & Comar, D. (1994). ENANTIOSELECTIVE SYNTHESIS OF NCA (S)-L-([ALPHA-C-11]METHYL)-TRYPTOPHAN. Applied Radiation and Isotopes, 45 (6), 651-653. doi:10.1016/0969-8043(94)90242-9 |
Salmon, E., Sadzot, B., Maquet, P., Degueldre, C., Lemaire, C., Rigo, P., Comar, D., & Franck, G. (1994). Differential diagnosis of Alzheimer's disease with PET. Journal of Nuclear Medicine, 35 (3), 391-8. |
Salmon, E., Sadzot, B., Maquet, P., Lemaire, C., Plenevaux, A., Damhaut, P., & Franck, G. (1994). Evolution of striatal metabolic and biochemical dysfunction in striato-nigral degeneration (SND). Journal of Neurology, 241 (S1), 36. |
Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., & Comar, D. (1994). 11C-alkylation on Al2O3/MF: a useful method for rapid labelling. Journal of Labelled Compounds and Radiopharmaceuticals, 35, 94. |
Schmitz, F., Plenevaux, A., Del Fiore, G., Lemaire, C., Comar, D., & Luxen, A. (1994). Al2O3/KF in radiochemistry: fast preparation of L-[11C-methyl]methionine without HPLC. Journal of Nuclear Medicine, 35, 82. |
Crouzel, C., Clark, J., Brihaye, C., Langström, B., Lemaire, C., Meyer, G., Nebeling, B., & Stone-Elander, S. (1993). Radiochemistry automation for PET. In G. Stöcklin & V. Pike (Eds.), Radiopharmaceuticals for Positron Emission Tomography (pp. 45-89). Kluwer Academic Publishers. |
Lemaire, C. (1993). Production of L-[18F]fluoroamino acids for protein synthesis: overview and recent developments in nucleophilic synthesis. In PET studies on Amino Acid Metabolism and Protein Synthesis (pp. 89-108). Kluwer Academic Publishers. |
Lemaire, C., Plenevaux, A., Cantineau, R., Christiaens, L., Guillaume, M., & Comar, D. (1993). NUCLEOPHILIC ENANTIOSELECTIVE SYNTHESIS OF 6-[F-18]FLUORO-L-DOPA VIA 2 CHIRAL AUXILIARIES. Applied Radiation and Isotopes, 44 (4), 737-744. doi:10.1016/0969-8043(93)90141-V |
Lemaire, C., Plenevaux, A., Damhaut, P., Guillaume, M., Christiaens, L., & Comar, D. (1993). NCA asymmetric synthesis of 2-[18F]fluoro-L-tyrosine. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 139. |
Plenevaux, A., Al-Darwich, M. J., Lemaire, C., Del Fiore, G., Christiaens, L., & Comar, D. (1993). Asymmetric synthesis of n.c.a. L-[2-11C]-4-chlorophenylalanine. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 156. |
Plenevaux, A., Lemaire, C., Palmer, A. J., Damhaut, P., & Comar, D. (1993). Non-activated 18F-fluorinated aromatic compounds through nucleophilic substitution and decarbonylation reactions using RhCl[P(C6H5)3]3. Journal of Labelled Compounds and Radiopharmaceuticals, 32, 114. |
Crouzel, C., Guillaume, M., Barre, L., Lemaire, C., & Pike, V. W. (1992). Ligands and tracers for PET studies of the 5-HT system--current status. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology, 19 (8), 857-70. doi:10.1016/0883-2897(92)90172-U |
Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1992). 2- and 4-[18F]fluorotropapride, two specific D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 43 (10), 1265-74. doi:10.1016/0883-2889(92)90205-S |
Lemaire, C., Damhaut, P., Plenevaux, A., Cantineau, R., Christiaens, L., & Guillaume, M. (1992). SYNTHESIS OF F-18 SUBSTITUTED AROMATIC-ALDEHYDES AND BENZYL BROMIDES, NEW INTERMEDIATES FOR NCA [F-18] FLUORINATION. Applied Radiation and Isotopes, 43 (4), 485-494. |
Lemaire, C., Plenevaux, A., & Comar, D. (1992). Feasibility of multumillicurie preparation of L-6-[18F]fluorodopa by nucleophilic asymmetric synthesis. European Journal of Nuclear Medicine, 19, 951. |
Plenevaux, A., Lemaire, C., Palmer, A. J., Damhaut, P., & Comar, D. (1992). SYNTHESIS OF NONACTIVATED F-18 FLUORINATED AROMATIC-COMPOUNDS THROUGH NUCLEOPHILIC-SUBSTITUTION AND DECARBOXYLATION REACTIONS. Applied Radiation and Isotopes, 43 (8), 1035-1040. |
Vaalburg, W., Coenen, H. H., Crouzel, C., Elsinga, P. H., Langstrom, B., Lemaire, C., & Meyer, G. (1992). Amino acids for the measurement of protein synthesis in vivo by PET. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology, 19 (2), 227-37. doi:10.1016/0883-2897(92)90011-M |
Cantineau, R., Damhaut, P., Plenevaux, A., Lemaire, C., & Guillaume, M. (1991). Synthesis and preliminary animal studies of [131I]iodotropapride: a cerebral dopamine D2 receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 368. |
Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1991). 4-[18F]Fluorotropapride, a specific D2 receptor ligand for PET. Journal of Nuclear Medicine, 32, 935. |
Damhaut, P., Cantineau, R., Lemaire, C., Plenevaux, A., Christiaens, L., & Guillaume, M. (1991). 2 and 4-[18F]fluorotropapride, two specific D2 receptor ligand for PET. European Journal of Nuclear Medicine, 18, 526. |
Lemaire, C., Cantineau, R., Guillaume, M., Plenevaux, A., & Christiaens, L. (1991). Fluorine-18-altanserin: a radioligand for the study of serotonin receptors with PET: radiolabeling and in vivo biologic behavior in rats. Journal of Nuclear Medicine, 32 (12), 2266-72. |
Lemaire, C., Damhaut, P., Cantineau, R., Plenevaux, A., & Guillaume, M. (1991). NCA synthesis of an N-w-[18F]fluoroethyl analog of altanserine, a serotonine S2 receptor ligand. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 374. |
Lemaire, C., Damhaut, P., Plenevaux, A., Cantineau, R., Christiaens, L., & Guillaume, M. (1991). Asymmetric synthesis of 4-[18F]fluoro-L-m-tyrosine via aromatic fluorination. Journal of Nuclear Medicine, 32, 935. |
Lemaire, C., Guillaume, M., Cantineau, R., Plenevaux, A., & Christiaens, L. (1991). NCA asymmetric synthesis of 6-[18F]fluoro-L-dopa. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 269. |
Lemaire, C., Guillaume, M., Cantineau, R., Plenevaux, A., & Christiaens, L. (1991). AN APPROACH TO THE ASYMMETRIC-SYNTHESIS OF L-6-[F-18]FLUORODOPA VIA NCA NUCLEOPHILIC FLUORINATION. Applied Radiation and Isotopes, 42 (7), 629-635. |
Lemaire, C., Guillaume, M., Plenevaux, A., Cantineau, R., Damhaut, P., & Christiaens. (1991). 18F-substituted aromatic aldehydes, key intermediates for nca radiosyntheses. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 134. |
Plenevaux, A., Cantineau, R., Labar, D., Lemaire, C., & Guillaume, M. (1991). Routine production and improvement in the purification of 3-N-(2'-[18F]fluoroethyl)spiperone for clinical use. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 382. |
Plenevaux, A., Guillaume, M., Brihaye, C., Lemaire, C., & Cantineau, R. (1991). Chemical processing for the production of carrier free selenium-73 from germanium and arsenic targets and synthesis of L-[73Se]selenomethionine. Journal of Labelled Compounds and Radiopharmaceuticals, 30, 100. |
Sadzot, B., Lemaire, C., Cantineau, R., Hermanne, J. P., Plenevaux, A., Maquet, P., Salmon, E., Degueldre, C., Guillaume, M., & Franck, G. (1991). Serotonine-S2 receptor imaging with [18F]altanserin and PET. Results in young normal controls. Journal of Nuclear Medicine, 32, 980. |
Salmon, E., Maquet, P., Sadzot, B., Degueldre, C., Lemaire, C., & Franck, G. (1991). Decrease of frontal metabolism demonstrated by positron emission tomography in a population of healthy elderly volunteers. Acta Neurologica Belgica, 91 (5), 288-95. |
Cantineau, R., Damhaut, P., Plenevaux, A., Lemaire, C., & Guillaume, M. (26 August 1990). [131I]iodotropapride: a cerebral dopamine D2 receptor ligand [Poster presentation]. 5th Congress - World Federation of Nuclear Medicine & Biology, Montréal, Canada. |
Lemaire, C., Sadzot, B., Cantineau, R., Plenevaux, A., Salmon, E., Franck, G., & Guillaume, M. (22 August 1990). [18F]Altansérine: nouveau radioligand des récepteurs sérotoninergiques pour la tomographie par émission de positons (TEP) [Poster presentation]. XXIXème Colloque de Médecine Nucléaire de Langue Française, Québec, Canada. |
Sadzot, B., Lemaire, C., Cantineau, R., Salmon, E., Plenevaux, A., Franck, G., & Guillaume, M. (19 June 1990). Imaging serotonin-S2 receptors in humans with PET and the selective S2 antagonist [18F]altanserin. Preliminary results. Journal of Nuclear Medicine, 31, 1584. |
Lemaire, C., Guillaume, M., Cantineau, R., & Christiaens, L. (1990). No-carrier-added regioselective preparation of 6-[18F]fluoro-L-dopa. Journal of Nuclear Medicine, 31 (7), 1247-1251. |
Plenevaux, A., Cantineau, R., Brihaye, C., Lemaire, C., Christiaens, L., & Guillaume, M. (1990). Synthesis and tissue distribution of four Se-labeled tertiary amines, potential brain pH imaging agents. International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology, 17 (6), 601-7. doi:10.1016/0883-2897(90)90136-O |
Plenevaux, A., Guillaume, M., Brihaye, C., Lemaire, C., & Cantineau, R. (1990). Chemical processing for production of no-carrier-added selenium-73 from germanium and arsenic targets and synthesis of L-2-amino-4-([73Se]methylseleno) butyric acid (L-[73Se]selenomethionine). International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 41 (9), 829-38. doi:10.1016/0883-2889(90)90060-T |
de Landsheere, C., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Del Fiore, C., Lemaire, C., Degueldre, C., Peters, J. P., Quaglia, L., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (September 1987). Viabilité myocardique après infarctus du myocarde traité par fibrinolyse: évaluation directe par tomographie à émission de positons combinant une étude régionale de la perfusion et de la captation glucidique [Poster presentation]. Congrès de Médecine Nucléaire, Liège, Belgium. |
de landsheere, C. M., Raets, D., Pierard, L., Berthe, C., Legrand, V., Crochelet, L., Chapelle, J.-P., Lemaire, C., del Fiore, G., Guillaume, M., Lamotte, D., Kulbertus, H., & Rigo, P. (1987). Thrombolysis in anterior myocardial infarction: effect on regional viability studied with positon emission tomography. Circulation, 76 (suppl.IV), 5. |
Lemaire, C., Guillaume, M., Christiaens, L., Palmer, A., & Cantineau, R. (1987). A New Route for the Synthesis of [18f]Fluoroaromatic Substituted Amino Acids: No Carrier Added L-P-[18f]Fluorophenylalanine. International Journal of Radiation Applications and Instrumentation. Part A, Applied Radiation and Isotopes, 38 (12), 1033-8. doi:10.1016/0883-2889(87)90066-9 |
Lemaire, C., Luxen, A., Christiaens, L., & Guillaume, M. (May 1983). Synthesis of chalcogeno lactones. II. 3, 4-dihydro-1 H-2-benzothiin-3-one, 3,4-dihydro-1H-2-benzoselenin-3-one and 3,4-dihydro-1H-2-benzotellurin-3-one. Journal of Heterocyclic Chemistry, 20 (3), 811-812. doi:10.1002/jhet.5570200362 |